⌘K

Home/Filings/4/0001209191-23-038597

4//SEC Filing

Allison David D. 4

Accession 0001209191-23-038597

CIK 0001445499other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 6:36 PM ET

Size

5.4 KB

Accession

0001209191-23-038597

Insider Transaction Report

Form 4

Period: 2023-06-16

IMPEL PHARMACEUTICALS INCIMPL

Allison David D.

Director

Transactions

Award
Stock Option (right to buy)
2023-06-16+13,222→ 13,222 total
Exercise: $1.34Exp: 2033-06-15→ Common Stock (13,222 underlying)

Footnotes (1)

[F1]The option is 100% vested on June 16, 2024.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMPEL PHARMACEUTICALS INC

CIK 0001445499

Entity typeother

Related Parties

1

filerCIK 0001853903

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 6:36 PM ET
Size: 5.4 KB

View on SEC.gov